Circulating very-low-density lipoprotein from subjects with impaired glucose tolerance accelerates adrenocortical cortisol and aldosterone synthesis

Hormone and Metabolic Research

Volumn 45, Issue 2, 2013, Pages 169-172

  Saha, S ^a   Schwarz, P E H ^a   Bergmann, S ^a   Bornstein, S R ^a   Graessler, J ^a   Kopprasch, S ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

adrenal gland; aldosterone; cortisol; lipoproteins

Indexed keywords

ALDOSTERONE; GLUCOSE; HYDROCORTISONE; VERY LOW DENSITY LIPOPROTEIN;

ADRENAL GLAND; ADULT; ARTICLE; CLINICAL ARTICLE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IN VIVO STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WESTERN BLOTTING;

ADRENAL CORTEX; AGED; ALDOSTERONE; CELL LINE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROCORTISONE; HYPERGLYCEMIA; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PHOSPHORYLATION; PREDIABETIC STATE; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; UP-REGULATION;

EID: 84874115209     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1323844     Document Type: Article

References (26)

1. Liang F., Kapoun A. M., Lam A., Damm D. L., Quan D., O'Connell M., Protter A. A. B-Type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells. Endocrinology: 2007; 148 3722 3729
2. Saha S., Bornstein S. R., Graessler J., Kopprasch S. Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways. Cell Tissue Res: 2012; 348 71 80
3. Xing Y., Rainey W. E., Apolzan J. W., Francone O. L., Harris R. B., Bollag W. B. Adrenal Cell Aldosterone Production Is Stimulated by Very-Low-Density Lipoprotein (VLDL). Endocrinology: 2012; 153 721 731
4. Saha S., Willenberg H. S., Bornstein S. R., Graessler J., Kopprasch S. Diabetic lipoproteins and adrenal aldosterone synthesis-a possible pathophysiological link? Horm Metab Res: 2012; 44 239 244
5. Braschi S., Geoffrion M., Nguyen A., Gaudreau Y., Milne R. W. The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients. Diabetologia: 2006; 49 1394 1401
6. Adiels M., Olofsson S. O., Taskinen M. R., Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol: 2008; 28 1225 1236
7. Goodfriend T. L., Egan B., Stepniakowski K., Ball D. L. Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension: 1995; 25 30 36
8. Graudal N. A., Hubeck-Graudal T., Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev: 2011; 11 CD004022
9. Lopes H. F., Silva H. B., Soares J. A., Filho B., Consolim-Colombo F. M., Giorgi D. M., Krieger E. M. Lipid metabolism alterations in normotensive subjects with positive family history of hypertension. Hypertension: 1997; 30 629 631
10. Quinkler M., Born-Frontsberg E., Fourkiotis V. G. Comorbidities in primary aldosteronism. Horm Metab Res: 2010; 42 429 434
11. Reincke M., Meisinger C., Holle R., Quinkler M., Hahner S., Beuschlein F., Bidlingmaier M., Seissler J., Endres S. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry. Horm Metab Res: 2010; 42 435 439
12. Andrews R. C., Herlihy O., Livingstone D. E., Andrew R., Walker B. R. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab: 2002; 87 5587 5593
13. Graessler J., Pietzsch J., Westendorf T., Julius U., Bornstein S. R., Kopprasch S. Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor gamma gene expression in macrophages. Diabetologia: 2007; 50 1080 1088
14. Kopprasch S., Pietzsch J., Kuhlisch E., Graessler J. Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus. J Clin Endocrinol Metab: 2003; 88 1711 1716
15. Pietzsch J., Subat S., Nitzsche S., Leonhardt W., Schentke K. U., Hanefeld M. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition. Biochim Biophys Acta: 1995; 1254 77 88
16. Younis N., Charlton-Menys V., Sharma R., Soran H., Durrington P. N. Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro. Atherosclerosis: 2009; 202 162 168
17. Younis N., Sharma R., Soran H., Charlton-Menys V., Elseweidy M., Durrington P. N. Glycation as an atherogenic modification of LDL. Curr Opin Lipidol: 2008; 19 378 384
18. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B. W., Shaltiel S., Stadtman E. R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol: 1990; 186 464 478
19. Haffner S. M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med: 1998; 339 229 234
20. Bruehl H., Rueger M., Dziobek I., Sweat V., Tirsi A., Javier E., Arentoft A., Wolf O. T., Convit A. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab: 2007; 92 2439 2445
21. Kantorovich V., Koch C. A., Chrousos G. P. Hypertension in patients with Cushing syndrome. In: Koch C. A., Chrousos G. P. (eds.). Endocrine Hypertension. New York Springer: 2012
22. Melcescu E., Griswold M., Xiang L., Belk S., Montgomery D., Bray M., Delben K. S., Uwaifo G. I., Marshall G. D., Koch C. A. Prevalence and cardiometabolic associations of the glucocorticoid receptor gene polymorphisms N363S and BclI in obese and non-obese black and white Mississippians. Hormones (Athens): 2012; 11 166 177
23. Bassett M. H., White P. C., Rainey W. E. The regulation of aldosterone synthase expression. Mol Cell Endocrinol: 2004; 217 67 74
24. Pilon A., Martin G., Bultel-Brienne S., Junquero D., Delhon A., Fruchart J. C., Staels B., Clavey V. Regulation of the scavenger receptor BI and the LDL receptor by activators of aldosterone production, angiotensin II and PMA, in the human NCI-H295R adrenocortical cell line. Biochim Biophys Acta: 2003; 1631 218 228
25. Li J., Feltzer R. E., Dawson K. L., Hudson E. A., Clark B. J. Janus kinase 2 and calcium are required for angiotensin II-dependent activation of steroidogenic acute regulatory protein transcription in H295R human adrenocortical cells. J Biol Chem: 2003; 278 52355 52362
26. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med: 2000; 342 145 153